Alternative Treatments Post-GLP-1 Transitioning off GLP-1 medications doesnt mean your journey to better health has to end
Severe cases may require hospitalization, feeding tubes, or surgical intervention
But a Hunterbrook Media investigation reveals that the compounder Hims has partnered with to manufacture these drugs BPI Labs LLC is wholly owned by Belcher Pharmaceuticals LLC, a business with a history of FDA scrutiny and former executives convicted of fraud
You might choose compounded semaglutide for various reasons, like supply issues, personal preference, allergies, or additional ingredients to reduce side effects and improve effectiveness
When asked in February 2026 where they would go if they wanted to learn more about GLP-1s, 85 percent of adults say they would talk to a doctor or another medical professional, 37 percent would visit a medical website, and 18 percent would read drug manufacturers patient education materials